TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 4 filers reported holding TANDEM DIABETES CARE INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $400,495 | -23.7% | 19,299 | -7.9% | 0.00% | -100.0% |
Q2 2023 | $524,871 | -74.3% | 20,955 | -54.1% | 0.00% | -50.0% |
Q4 2022 | $2,046,057 | +9.7% | 45,636 | +17.2% | 0.00% | -33.3% |
Q3 2022 | $1,865,000 | -23.2% | 38,944 | -5.1% | 0.00% | 0.0% |
Q2 2022 | $2,429,000 | -16.3% | 41,041 | +64.8% | 0.00% | -25.0% |
Q1 2022 | $2,902,000 | +508.4% | 24,901 | +525.7% | 0.00% | – |
Q3 2021 | $477,000 | -65.9% | 3,980 | -72.3% | 0.00% | -100.0% |
Q2 2021 | $1,397,000 | +349.2% | 14,359 | +304.9% | 0.00% | – |
Q1 2021 | $311,000 | -61.7% | 3,546 | -58.4% | 0.00% | -100.0% |
Q4 2020 | $812,000 | -7.5% | 8,530 | +11.3% | 0.00% | 0.0% |
Q3 2020 | $878,000 | +84.1% | 7,667 | +59.1% | 0.00% | 0.0% |
Q2 2020 | $477,000 | +34.7% | 4,819 | -9.9% | 0.00% | 0.0% |
Q1 2020 | $354,000 | +12.4% | 5,349 | +1.7% | 0.00% | 0.0% |
Q4 2019 | $315,000 | -1.6% | 5,262 | -3.0% | 0.00% | 0.0% |
Q3 2019 | $320,000 | +22.1% | 5,427 | +33.5% | 0.00% | – |
Q2 2019 | $262,000 | – | 4,064 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |